User: Guest  Login
Title:

Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?

Document type:
Journal Article
Author(s):
Gitt, AK; Halle, M; Hanefeld, M; Kellerer, M; Marx, N; Meier, JJ; Schumm-Draeger, PM; Bramlage, P; Tschöpe, D
Abstract:
Patients with type 2 diabetes are at high risk for developing heart failure. Evidence-based treatment recommendations with respect to the specific benefits or possible hazards of antidiabetic treatment are scarce.In a systematic search we only identified randomized, controlled trials for thiazolidinediones. Further evidence is largely based on subgroup analyses of larger intervention studies in mostly systolic heart failure, on observational studies, or on registries. Acknowledging this lack of...     »
Journal title abbreviation:
Eur J Heart Fail
Year:
2012
Journal volume:
14
Journal issue:
12
Pages contribution:
1389-400
Language:
eng
Fulltext / DOI:
doi:10.1093/eurjhf/hfs136
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/22977264
Print-ISSN:
1388-9842
TUM Institution:
Poliklinik für Präventive und Rehabilitative Sportmedizin
 BibTeX